Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-28

Clinical Trial Update: Ovarian Aging in Low Grade Glioma (LGG) Treated With Temozolomide

View source ↗

Summary

A clinical trial investigating ovarian aging in patients with low grade glioma treated with temozolomide was terminated; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Temozolomide (Temozolomide)

Snippet

Sponsor: University of California, San Francisco | Conditions: Low Grade Glioma | Status: TERMINATED | Results posted: 2014-08-28